Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Transport and binding of methotrexate in vivo.

× No keyword cloud information.

35 in total

1. Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

Authors: H Takanaga; A Ohnishi; H Matsuo; H Murakami; H Sata; K Kuroda; A Urae; S Higuchi; Y Sawada
Journal: Br J Clin Pharmacol Date: 2000-01 Impact factor: 4.335

2. Distribution of HEOD (dieldrin) in mammals: II. some applications of the preliminary model.

Authors: F T Lindstrom; J W Gillett; S E Rodecap
Journal: Arch Environ Contam Toxicol Date: 1975 Impact factor: 2.804

3. Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man.

Authors: B Montandon; R J Roberts; L J Fischer
Journal: J Pharmacokinet Biopharm Date: 1975-08

4. Pharmacokinetics of YM466, a new factor Xa inhibitor, in rats and dogs.

Authors: Yuji Mano; Takashi Usui; Hidetaka Kamimura
Journal: Eur J Drug Metab Pharmacokinet Date: 2004 Jan-Mar Impact factor: 2.441

5. Pharmacokinetic modeling of the dogfish shark (Squalus acanthias): distribution and urinary and biliary excretion of phenol red and its glucuronide.

Authors: P M Bungay; R L Dedrick; A M Guarino
Journal: J Pharmacokinet Biopharm Date: 1976-10

6. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats.

Authors: Yoshihiro Miyaji; Yuji Kasuya; Yoshitake Furuta; Atsushi Kurihara; Masayuki Takahashi; Ken-Ichi Ogawara; Takashi Izumi; Osamu Okazaki; Kazutaka Higaki
Journal: Pharm Res Date: 2012-06-23 Impact factor: 4.200

Transport and binding of methotrexate in vivo.

1. Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

2. Distribution of HEOD (dieldrin) in mammals: II. some applications of the preliminary model.

3. Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man.

4. Pharmacokinetics of YM466, a new factor Xa inhibitor, in rats and dogs.

5. Pharmacokinetic modeling of the dogfish shark (Squalus acanthias): distribution and urinary and biliary excretion of phenol red and its glucuronide.

6. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats.

7. Distribution pharmacokinetics of warfarin in the rat, a non-linear multicompartment model.

8. Distribution of HEOD (dieldrin) in mammals: III. Transport--transfer.

9. Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.

10. The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma.